Author

Ashwini Sakrepatna Nagaraj

University of HelsinkiORCID 0000-0002-9048-2116Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:spatial transcriptomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

Anna VähärautioiD· 2 shared Anni VirtaneniD· 2 shared Anniina FärkkiläiD· 2 shared Erdoğan Pekcan ErkaniD· 2 shared Iga NiemieciD· 2 shared Matilda SalkoiD· 2 shared Sampsa HautaniemiiD· 2 shared Ulla‐Maija HaltiaiD· 2 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Anna VähärautioORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCancer CellPeer-reviewedDec 1, 2024

Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer

Inga-Maria P. Launonen, Iga Niemiec, María Mercedes Hincapié-Otero…·Anniina Färkkilä

This study shows chemotherapy causes myeloid-driven spatial T-cell exhaustion in ovarian cancer by altering immune cell states and interactions, suggesting new immunotherapy approaches.

103 citationstop 1%

humanscRNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 15, 2024

Patient-derived functional immuno-oncology platform identifies responders to ATR inhibitor and immunotherapy combinations in ovarian cancer

Ashwini Sakrepatna Nagaraj, Matilda Salko, Aditi Sirsikar…·Anniina Färkkilä

4 citations

humanbulk RNA-seq

𝕏 PostBluesky